Skip to main content
. 2020 Apr 17;98(5):skaa113. doi: 10.1093/jas/skaa113

Table 4.

Effect of treatment on mucosal cytokines2, disaccharidase activity3, and secretory immunoglobulin A4 in the ilea of weaned pigs challenged with F18 ETEC

Treatment1
Item NC PC DFM1 DFM2 SEM P-value
IFNγ 7.04 7.96 5.07 7.47 1.57 0.521
IL-1rα 20.56 24.06 19.21 16.48 3.69 0.828
IL-1α 1.66 1.88 2.11 1.70 0.27 0.421
IL-1β 8.30 9.59 12.08 7.55 1.59 0.397
IL-2 0.49 0.69 0.57 0.52 0.11 0.465
IL-4 0.79 0.48 0.58 0.48 0.17 0.508
IL-6 0.35 0.57 0.86 0.24 0.20 0.212
IL-8 240.20b 343.06a 288.07ab 283.42ab 29.13 0.011
IL-10 0.30 0.25 0.27 0.25 0.04 0.302
IL-12 3.06 3.81 3.14 4.35 0.44 0.214
IL-18 220.69 227.45 223.82 229.00 27.64 0.854
Lactase 0.07 0.11 0.03 0.13 0.05 0.511
Sucrase 1.81c 4.49a 2.56b 4.72a 0.58 0.003
Maltase 7.39c 14.16ab 9.61bc 20.91a 2.64 0.004
sIgA 2.50a 1.11b 1.37b 0.95b 0.33 0.011

1NC (n = 10); PC (n = 9); DFM1 = PC + direct-fed microbial 1 (n = 8; three strains of Bacillus amyloliquefaciens; 7.5 × 105 cfu/g of feed); DFM2 = PC + direct-fed microbial 2 (n = 7; two strains of B. amyloliquefaciens and 1 strain of Bacillus subtilis; 1.5 × 105 cfu/g of feed). Supplementation rates were based on manufacturer’s recommendations (Danisco Animal Nutrition).

2ng/g of mucosa.

3U/min/g of protein.

4μg/mg of protein.

a–c Means with differing superscripts indicate a significant (P < 0.05) difference.